Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for perioperative depressive symptoms in children
ChiCTR2500107873Phase 4Recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in major depressive disorder (MDD) (3 arms), sponsored by Beijing Children's Hospital. Primary endpoint: Change in depressive state (DSRSC score). Started Aug 2025; status: recruiting.
02
Drugs
esketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2500107873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107873.